{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:20:41Z","timestamp":1761844841264},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T00:00:00Z","timestamp":1485129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ihj.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T19:02:39Z","timestamp":1509735759000},"page":"492-496","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Statins everyday versus alternate days: Is there a difference in myalgia rates?"],"prefix":"10.1016","volume":"70","author":[{"given":"Ramsha","family":"Riaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleena Zehra","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Salman","family":"Ul Haq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Ali Raza","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusra","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jehanzeb Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Mohiuddin","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassaan","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khizar","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor-ul-ain","family":"Zehra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madiha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain Asif","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaneez","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ihj.2017.10.018_bib0005","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/clpt.2014.121","article-title":"Phenotype standardization for statin-Induced myotoxicity","volume":"96","author":"Alfirivec","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/0253-7613.96326","article-title":"Efficacy of alternate-day versus everyday dosing of atorvastatin","volume":"44","author":"Pramanic","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ihj.2017.10.018_bib0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/1472-6963-14-414","article-title":"Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis","volume":"14","author":"Fleetcroft","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"20","key":"10.1016\/j.ihj.2017.10.018_bib0020","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2017.10.018_bib0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.33549\/physiolres.932865","article-title":"Statin-associated myopathy: from genetic predisposition to clinical management","volume":"63","author":"Vrablik","year":"2014","journal-title":"Physiol Res"},{"key":"10.1016\/j.ihj.2017.10.018_bib0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1734-1140(11)70601-6","article-title":"Statin-induced myopathies","volume":"63","author":"Tomaszewski","year":"2011","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.ihj.2017.10.018_bib0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/JES.0b013e31826c169e","article-title":"Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomes","volume":"40","author":"Parker","year":"2012","journal-title":"Exerc Sport Sci Rev"},{"issue":"5","key":"10.1016\/j.ihj.2017.10.018_bib0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4103\/0972-124X.157876","article-title":"Association of periodontal and cardiovascular diseases: South-Asian studies 2001\u20132012","volume":"19","author":"Bokhari","year":"2015","journal-title":"J Indian Soc Periodontol"},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0045","first-page":"258","article-title":"Coronary heart disease risk-factor profile in a lower middle class urban community in Pakistan","volume":"11","author":"Aziz","year":"2005","journal-title":"East Mediterr Health J"},{"issue":"23","key":"10.1016\/j.ihj.2017.10.018_bib0050","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1161\/hc4701.099488","article-title":"Global burden of Cardiovascular diseases part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies","volume":"104","author":"Yusuf","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ihj.2017.10.018_bib0055","first-page":"623","article-title":"HDL cholesterol\u2013how do I raise my patient\u2019s good cholesterol?","volume":"62","author":"Shaikh","year":"2012","journal-title":"J Pak Med Assoc."},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0060","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.0030050","article-title":"Evidence-based prescribing of statins: a developing world perspective","volume":"3","author":"Ong","year":"2006","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.ihj.2017.10.018_bib0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejim.2012.02.006","article-title":"Non-every day statin administration \u2212 A literature review","volume":"23","author":"Elis","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0070","first-page":"27","article-title":"Alternate day versus once daily atorvastatin for primary prevention of (CHD) in Na\u00efve patients of dyslipidemia","volume":"8","author":"Ghia","year":"2014","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4330\/wjc.v8.i3.247","article-title":"Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: current state and future directions","volume":"8","author":"Bilen","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/j.ihj.2017.10.018_bib0080","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2017.10.018_bib0085","first-page":"2337","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"33","author":"Pasternak","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2017.10.018_bib0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.trsl.2008.11.002","article-title":"Low serum 25 (OH) vitamin D levels (<\u200932ng\/mL) are associated with reversible myositis-myalgia in statin-treated patients","volume":"153","author":"Ahmed","year":"2009","journal-title":"Transl Res"},{"issue":"4","key":"10.1016\/j.ihj.2017.10.018_bib0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5455\/2319-2003.ijbcp20140819","article-title":"Lipid modifying action of atorvastatin in escalating doses in patients of coronary artery disease","volume":"3","author":"Paul","year":"2014","journal-title":"Int J Basic Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.ihj.2017.10.018_bib0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/fampra\/cmp006","article-title":"Statin use and its association with musculoskeletal symptoms\u2014a cross-sectional study in primary care settings","volume":"26","author":"Mo\u00dfhammer","year":"2009","journal-title":"Fam Pract"},{"issue":"6","key":"10.1016\/j.ihj.2017.10.018_bib0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3949\/ccjm.78a.10073","article-title":"Statin myopathy: a common dilemma not reflected in clinical trials","volume":"78","author":"Fernandez","year":"2011","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1345\/aph.1K604","article-title":"Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance","volume":"42","author":"Backes","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.amjcard.2008.09.095","article-title":"Once-a-week rosuvastatin (2. 5 to 20\u2009mg) in patients with a previous statin intolerance","volume":"103","author":"Ruisinger","year":"2009","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ihj.2017.10.018_bib0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/107424840300800205","article-title":"Efficacy of alternate-day dosing versus daily dosing of atorvastatin","volume":"8","author":"Jafari","year":"2003","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ihj.2017.10.018_bib0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/DMSO.S11244","article-title":"Treating statin-intolerant patients","volume":"4","author":"Arca","year":"2011","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1016\/j.ihj.2017.10.018_bib0130","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1592\/phco.22.13.1110.33518","article-title":"Daily dosing versus alternate-day dosing of simvastatin in patients with hypercholesterolemia","volume":"22","author":"Copher","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.ihj.2017.10.018_bib0135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2011.09.006","article-title":"Impact of 10mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers","volume":"413","author":"Li","year":"2012","journal-title":"Clinica Chimica Acta"},{"issue":"2","key":"10.1016\/j.ihj.2017.10.018_bib0140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejim.2015.01.002","article-title":"Risk identification and possible countermeasures for muscle adverse effects during stain therapy","volume":"26","author":"Magni","year":"2015","journal-title":"Eur J Inter Med"},{"issue":"8","key":"10.1016\/j.ihj.2017.10.018_bib0145","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.amjcard.2005.12.013","article-title":"National lipid association statin safety task force muscle safety expert panel: an assessment of statin safety by muscle experts","volume":"97","author":"Thompson","year":"2006","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ihj.2017.10.018_bib0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjcard.2011.08.045","article-title":"Effect of statins on creatine kinase levels before and after a marathon run","volume":"109","author":"Parker","year":"2012","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.ihj.2017.10.018_bib0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5\u20136","key":"10.1016\/j.ihj.2017.10.018_bib0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1023\/B:CARD.0000015861.26111.ab","article-title":"A comprehensive description of muscle symptoms associated with lipid-lowering drugs","volume":"17","author":"Franc","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"10.1016\/j.ihj.2017.10.018_bib0165","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1097\/00005768-199810000-00005","article-title":"Reduced oxidized LDL levels after a 10-month exercise program","volume":"30","author":"Vasankari","year":"1998","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"10.1016\/j.ihj.2017.10.018_bib0170","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nefro.2015.05.016","article-title":"The effect of some medications given to CKD patients on vitamin D levels","volume":"35","author":"Yuste","year":"2015","journal-title":"Nefrologia"},{"key":"10.1016\/j.ihj.2017.10.018_bib0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2014.10.118","article-title":"Analysis of vitamin D levels in patients with and without statin-associated myalgia. A systematic review and meta-analysis of 7 studies with 2420 patients","volume":"178","author":"Michalska-Kasiczak","year":"2015","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2017.10.018_bib0180","first-page":"42","article-title":"Low plasma vitamin D levels and muscle-related adverse effects in statin users","volume":"16","author":"Eisen","year":"2014","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"10.1016\/j.ihj.2017.10.018_bib0185","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.2011.04321.x","article-title":"Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins","volume":"77","author":"Kurnik","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ihj.2017.10.018_bib0190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2008-7802.183652","article-title":"Simvastatin treatment does not affect serum Vitamin D concentrations in patients with dyslipidemia: a randomized double-blind placebo-controlled cross-over trial","volume":"7","author":"Mazidi","year":"2016","journal-title":"Int J Prev Med"},{"issue":"3","key":"10.1016\/j.ihj.2017.10.018_bib0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/1947-2714.153919","article-title":"Statin intolerance because of myalgia, myositis, myopathy, or myonecrosis can in most cases be safely resolved by vitamin D supplementation","volume":"7","author":"Khayznikov","year":"2015","journal-title":"N Am J Med Sci"},{"key":"10.1016\/j.ihj.2017.10.018_bib0200","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00001648-200109000-00017","article-title":"Lipid-lowering drugs and risk of myopathy: a population-based follow-up study","volume":"12","author":"Gaist","year":"2001","journal-title":"Epidemiology"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217300482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483217300482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T02:39:43Z","timestamp":1603247983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483217300482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0019483217300482"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2017.10.018","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins everyday versus alternate days: Is there a difference in myalgia rates?","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}